WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 5'1401 Infant (under 12 months) mortality rate: 162
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 182

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 2'769  2'755  2'741  2'730  2'719  2'582  2'365  2'132 
Births 50  51  51  51  52  57  61  62 
Surviving infants 49  49  50  50  50  55  59  60 
Pop. less than 5 years 254  254  246  245  241  283  290  283 
Pop. less than 15 years 773  787  796  807  814  843  831  858 
Female 15-49 years 732  726  722  718  715  673  594  484 

Number of reported case

(Click for retrospective incidence data for Jamaica)
Diphtheria 13 
Japanese encephalitis
Measles 3'651  36 
Mumps 10 
Pertussis 23  13 
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total) 10 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Jamaica)
Vaccine year result method % card seen                                                
BCG 2004  96  MICS   74.1  96  99*  95  94  92  93  98  38 
DTP1 2004  96  MICS   74.1  95  94  92  91  88  87 
DTP3 2004  87  MICS   74.1  96  92  94  90  87  86  86  24 
HepB_BD         
HepB3 2004  98  EPI   100.0  96  92  94  90  89 
Hib3 2004  98  EPI   100.0  96  91  94  90  87 
JapEnc         
MCV 2004  91  MICS   74.1  93  88  89  88  88  88  74 
MCV2          76  60  57  79  80 
PCV1          14 
PCV3          17 
Pol3 2004  86  MICS   74.1  96  93  94  90  87  86  87  34 
Rota1         
Rota_last         
Rubella1          93  88  89  88  87 
TT2plus          59  67  63  53  49  55 
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Jamaica)
BCG 96  99  95  94  92  94  98  38 
DTP1 99  99  99  99  99  97  95  48 
DTP3 99  99  99  99  99  93  86  24 
HepB3 99  99  99  99  99 
Hib3 99  99  99  99  99 
MCV 93  88  89  88  88  88  74 
PAB 80  80  80  62  58  51 
PCV3
Pol3 99  99  99  99  99  95  87  34 
Rota_last

Number of districts in the country 13  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 77
From 80 to 89% 15
From 50 to 79% 8
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 6 weeks; 3, 5-6, 18 months; 4-6 years; Yes Pertussis contrindication
DTwP 18 months; 4-6 years; Yes
DTwPHibHep 6 weeks; 3, 5-6 months; Yes
HIB 6 weeks; 3, 5-6 months; Yes pertussis contrindication
HepB 6 weeks; 3, 5-6 months Yes or 1st contact, +1, +6 months (for at risk persons)
IPV 6 weeks; 3, 5-6, 18 months; 4-6 years; Yes immunocompromised
Influenza Yes Health workers & children with chronic diseases
MMR 12-23 months; 4-6 years; Yes
OPV 6 weeks; 3, 5-6, 18 months; 4-6 years; Yes
Pneumo_conj 2, 4, 6, 18 months; Yes Children with sickle cell disease
Td 4-6 years; Yes PW and adults
YF Yes travelers to endemic countries

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR No  No  No  No  No  No  No 
What years does the MYP cover? number             NA 
Nº of districts with microplans that include activities to raise immunization coverage number 13  13  13  13  13  13  13 

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR No  No  No         

System performance

Total number of districts in country number 13  13  13  13  13  13  13 
Nº districts with DTP3 coverage >=80% number 12  11  11  13  11 
% of districts with DTP3 coverage >=80% From 0 to 100% 92  85  85  100  69  85  69 
Nº districts with measles (MCV1) coverage >=95% number    
% of districts with MCV1 coverage >=95% From 0 to 100% 69  15  31     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 100  100  100  100    100  100 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.